Importance of total radiation dose and overall treatment time in T1 early glottic cancer

Authors

  • B.K. Jeong Department of Radiation Oncology, School of Medicine and Gyeongsang National University Hospital, Jinju, Korea
  • B.O. Choi Department of Radiation Oncology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
  • H. Jeong Department of Radiation Oncology, School of Medicine and Gyeongsang National University Hospital, Jinju, Korea
  • H.S. Choi Department of Radiation Oncology, School of Medicine and Gyeongsang National University Changwon Hospital, Changwon, Korea
  • H.S. Jang Department of Radiation Oncology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
  • J.H. Song Department of Radiation Oncology, School of Medicine and Gyeongsang National University Changwon Hospital, Changwon, Korea
  • K.M. Kang Department of Radiation Oncology, School of Medicine and Gyeongsang National University Changwon Hospital, Changwon, Korea
  • Y.H. Lee Department of Radiation Oncology, School of Medicine and Gyeongsang National University Hospital, Jinju, Korea
Abstract:

Background: In this study, we retrospectively reviewed the treatment outcome of 63 patients with T1 early glottic cancer treated with RT alone to determine the treatment outcome and the prognostic factors affecting local control. Materials and Methods: All patients were treated by 6 MV photons with conventional bilateral fields up to a median dose of 66 Gy in 33 fractions. Results: The 5-year local control rate and overall survival were 77.7% and 93.1%, respectively. The total radiation dose with a cut-off value of 66 Gy was a significant prognostic factor for local control. The 5-year local control rate was 54.5% in patients treated with less than 66 Gy compared to 85.7% in patients treated with 66 Gy or higher dose (p = 0.014). In subgroup analysis, in patients who received 66 Gy or higher doses, all recurrences developed in whose overall treatment time was 49 days or longer, although the statistical significance was marginal (p = 0.066). Conclusion: This study showed that a total dose of 66 Gy or higher is required for the treatment of T1 glottic cancer, and delivering the total dose within 49 days seems important for local control.  

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Radiotherapy for glottic T1N0 carcinoma with slight hypofractionation and standard overall treatment time: importance of overall treatment time.

OBJECTIVE We retrospectively investigated treatment outcomes in patients with glottic T1 carcinoma treated with 65 Gy in 26 fractions four times a week and discuss the importance of the overall treatment time. METHODS Two hundred one patients with glottic T1 carcinoma were evaluated. Sixty-five Gray in 26 fractions were delivered for 200 patients, whereas 1 patient received 62.5 Gy in 25 frac...

full text

Short treatment time and excellent treatment outcome in accelerated hyperfractionated radiotherapy for T1 glottic cancer.

Accelerated hyperfractionated radiotherapy was performed as treatment for patients with T1 glottic cancer, and its utility was evaluated based on treatment outcomes and adverse effects. Fifty-eight men who had undergone radiotherapy were retrospectively reviewed. Tumor classification was Tis in 4 patients, T1a in 38, and T1b in 16. Histological examination revealed squamous cell carcinoma in 55...

full text

Calculation of total dose and dose equivalent distribution in the treatment of lung cancer using MR-guided carbon therapy

Nowadays, in order to improve the accuracy of treatment in radiation therapy, there are many attempts to use magnetic resonance imaging (MRI) due to the advantages of excellent soft tissue contrast and ultra-fast pulse sequences. On the other hand, carbon-ion radiation therapy is developing rapidly due to the benefits of greater relative biological effectiveness (RBE) and the application in the...

full text

Voice quality after radiation therapy for early glottic cancer.

OBJECTIVE To evaluate the voices of irradiated patients with early glottic carcinoma and to compare these with the voices of healthy volunteers. DESIGN Case-control study. SETTING University Department of Otorhinolaryngology and Cervicofacial Surgery, University of Ljubljana, Ljubljana, Slovenia. SUBJECTS AND METHODS The voice samples (sustained vowel) of 50 patients (44 men and 6 women) ...

full text

Analysis of Hip Joint Dose in Prostate Cancer Radiation Therapy: A Dosimetric Comparison of Treatment Plans

Background and purpose: Radiation therapy as a part of cancer treatment is used in almost 50-60% of involved cases. In prostate cancer radiation therapy, a large volume of pelvis is irradiated, so, it is necessary to preserve sensitive organs around the treatment area, especially rectum and bladder. In this study, some dosimetric parameters such as minimum dose (Dmin), maximum dose (Dmax), mean...

full text

Management of Early Glottic Cancer

The management of early glottic cancer has evolved significantly over the past decade, with transoral laser (TOL) surgery and radiotherapy emerging as the two most prevalent treatment modalities. The selection of one modality over another continues to generate controversy. With both modalities showing similar efficacy with regard to survival and oncologic outcomes, the selection of one modality...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 16  issue None

pages  17- 24

publication date 2018-01

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023